Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: A case report

World Journal of Gastroenterology

Volumn 11, Issue 15, 2005, Pages 2364-2366

  Drebber, Uta ^a   Andersen, Matthias ^b   Kasper, Hans U ^a   Lohse, Peter ^c   Stolte, Manfred ^d   Dienes, Hans P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b St Vincenz Hospital   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Acid esterase; CESD; Diarrhea; Hydrolase; Liver biopsy; Pathology

Indexed keywords

LIVER ENZYME; MESSENGER RNA; BIK CHANNEL; CHOLESTEROL ESTER; CHOLESTEROL ESTERASE; INWARDLY RECTIFYING POTASSIUM CHANNEL; LIPA PROTEIN, HUMAN;

ADULT; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; CHILDHOOD DISEASE; CHOLESTEROL ESTER STORAGE DISEASE; CHRONIC DIARRHEA; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; EDEMA; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; INTESTINE BIOPSY; LACTOSE TOLERANCE; LIPID STORAGE; LIVER BIOPSY; SEQUENCE ANALYSIS; SMALL INTESTINE MUCOSA; SURVIVAL; ULTRASOUND; WEIGHT REDUCTION; AGE; CHRONIC DISEASE; DIARRHEA; HOSPITALIZATION; METABOLISM; PATHOLOGY; WOLMAN DISEASE;

ADULT; AGE FACTORS; CHOLESTEROL ESTERASE; CHOLESTEROL ESTERS; CHRONIC DISEASE; DIARRHEA; FEMALE; HUMANS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEVERITY OF ILLNESS INDEX; WEIGHT LOSS; WOLMAN DISEASE;

EID: 18744388293     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i15.2364     Document Type: Article

References (20)

1. Anderson RA, Bryson GM, Parks JS. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. Mol Genet Metab 1999; 68: 333-345
2. D'Agostino D, Bay L, Gallo G, Chamoles N. Cholesterol ester storage disease: Clinical, biochemical, and pathological studies of four new cases. J Pediatr Gastroenterol Nutr 1988; 7: 446-450
3. Aslanidis C, Ries S, Fehringer P, Buchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996; 33: 85-93
4. Lohse P, Maas S, Sewell AC, van Diggelen OP, Seidel D. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease. J Lipid Res 1999; 40: 221-228
5. Edelstein RA, Filling-Katz MR, Pentchev P, Gal A, Chandra R, Shawker T, Guzzetta P, Comly M, Kaneski C, Brady RO. Cholesteryl ester storage disease: A patient with massive splenomegaly and splenic abscess. Am J Gastroenterol 1988; 83: 687-692
6. Elleder M, Chlumska A, Hyanek J, Poupetova H, Ledvinova J, Maas S, Lohse P. Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol 2000; 32: 528-534
7. Elleder M, Chlumska A, Ledvinova J, Poupetova H. Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma. Virchows Arch 2000; 436: 82-87
8. Hanak J, Elleder M. Cholesterol ester storage disease (CESD). Cesk Pediatr 1984; 39: 721-725
9. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest 1993; 92: 2713-2718
10. Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf U, Assmann G. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 1995; 95: 491-494
11. Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 1994; 20: 329-331
12. Pagani F, Pariyarath R, Garcia R, Stuani C, Burlina AB, Ruotolo G, Rabusin M, Baralle FE. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res 1998; 39: 1382-1388
13. Lohse P, Maas S, Elleder M, Kirk JM, Besley GT, Seidel D. Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. J Lipid Res 2000; 41: 23-31
14. Levy R, Ostlund RE Jr, Schonfeld G, Wong P, Semenkovich CF. Cholesteryl ester storage disease: Complex molecular effects of chronic lovastatin therapy. J Lipid Res 1992; 33: 1005-1015
15. Gasche C, Aslanidis C, Kain R, Exner M, Helbich T, Dejaco C, Schmitz G, Ferenci P. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol 1997; 27: 744-750
16. Rassoul F, Richter V, Lohse P, Naumann A, Purschwitz K, Keller E. Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. Int J Clin Pharmacol Ther 2001; 39: 199-204
17. Leone L, Ippoliti PF, Antonicelli R, Balli F, Gridelli B. Treatment and liver transplantation for cholesterol ester storage disease. J Pediatr 1995; 127: 509-510
18. Ferry GD, Whisennand HH, Finegold MJ, Alpert E, Glombicki A. Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr 1991; 12: 376-378
19. Kale AS, Ferry GD, Hawkins EP. End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression. J Pediatr Gastroenterol Nutr 1995; 20: 95-97
20. Akcoren Z, Gogus S, Kocak N, Gurakan F, Ozen H, Yuce A. Cholesteryl ester storage disease: Case report during childhood. Pediatr Dev Pathol 1999; 2: 574-576